Transgene(FR:TNG)
€0.73+0.00 (+0.27%)
FR:TNG
Transgene financials statements
€0.73
At close:+0.00 (+0.27%)
Want to see FR:TNG full AI Analyst Report?
Transgene (TNG) Income Statement
8 Followers
Transgene Income Statement
Last quarter (Q2 2026), Transgene's total revenue was €272.00K, an increase of 1082.61% from the same quarter last year. In Q2, Transgene's net income was €-15.67M. See Transgene’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| € 490.00K | € 6.35M | € 7.90M | € 3.13M | € 9.99M | |
| € 490.00K | € -27.93M | € -21.69M | € -29.04M | € -22.89M | |
| € 34.48M | € 7.73M | € 8.36M | € 33.25M | € 33.74M | |
| Depreciation and Amortization | € 1.30M | € 1.28M | € 1.57M | € 1.69M | € 2.52M |
| € -39.77M | € -26.65M | € -28.44M | € -30.31M | € -16.55M | |
| € -41.07M | € -35.66M | € -30.05M | € -29.90M | € -23.52M | |
| € -3.17M | € 1.69M | € 7.72M | € -2.90M | € 4.16M | |
| € -44.24M | € -40.02M | € -22.33M | € -32.80M | € -19.54M | |
| € -37.52M | € -33.97M | € -22.33M | € -32.81M | € -20.00M | |
| Per Share Metrics | |||||
| Basic EPS | € -0.26 | € -0.29 | € -0.22 | € -0.33 | € -0.22 |
| Diluted EPS | € -0.26 | € -0.29 | € -0.22 | € -0.33 | € -0.22 |
| Weighted Average Shares Outstanding | 144.32M | 116.67M | 100.59M | 99.50M | 91.11M |
| Weighted Average Shares Outstanding (Diluted) | 144.32M | 116.67M | 100.59M | 99.50M | 91.11M |
Currency in EUR
